+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Clinical Trials Support Services Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 140 Pages
  • September 2023
  • Region: Global
  • Expert Market Research
  • ID: 5895166
The global clinical trials support services market was valued USD 22.5 billion in 2023, driven by protocol design, regulatory compliance, patient recruitment has led to market growth across the globe. The market size is anticipated to grow at a CAGR of 7.1% during the forecast period of 2024-2032 to achieve a value of USD 41.7 billion by 2032.

Clinical Trials Support Services: Introduction

Clinical trials support services play a crucial role in the healthcare and pharmaceutical sectors by providing essential assistance throughout the process of planning, conducting, and managing clinical trials. These trials are fundamental for evaluating the safety and efficacy of new medical interventions before they can be approved for wider use. The market for clinical trials support services encompasses a wide range of functions aimed at ensuring the successful execution of trials while adhering to regulatory standards. From protocol design and patient recruitment to data management and statistical analysis, these services contribute to the advancement of medical research and the development of innovative treatments.

Key Trends in Global Clinical Trials Support Services Market

  • Digital Transformation: The adoption of digital technologies, such as electronic data capture (EDC), remote monitoring, and eConsent, is transforming the way clinical trials are conducted. These technologies streamline data collection, enhance patient engagement, and enable real-time monitoring, leading to more efficient and cost-effective trials.
  • Decentralized Trials: The COVID-19 pandemic accelerated the shift towards decentralized and hybrid clinical trials, allowing patients to participate from their homes. This trend is likely to continue as it increases patient participation, reduces site-related challenges, and enhances trial diversity.
  • Real-world Evidence (RWE): Incorporating real-world data from sources like electronic health records and wearables is gaining prominence. RWE supplements traditional trial data, providing a broader understanding of treatment outcomes and patient experiences.
  • Patient-Centric Approach: Emphasizing patient-centricity by involving patients in trial design and offering convenient participation options improves patient recruitment, retention, and overall trial success.
  • Adaptive Trial Designs: Adaptive trials allow modifications based on interim data analysis, optimizing trial parameters and increasing the likelihood of successful outcomes.

Global Clinical Trials Support Services Market Segmentation

The market can be categorised into service type, phase, type of manufacturing sponsor and region.

Market Breakup by Service Type

Clinical Trial Site Management

  • Patient Recruitment Management
  • Patient Recruitment and Registry Services
  • Patient Retention
  • Others
  • IRB
  • Data Management
  • Administrative staff
  • Others

Market Breakup by Phase

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Market Breakup by Manufacturing Sponsor

  • Pharmaceutical and Biopharmaceutical
  • Medical Devices
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Clinical Trials Support Services Market Overview

The Clinical Trials Support Services market is a dynamic and integral segment of the healthcare and pharmaceutical industries, playing a pivotal role in advancing medical research and bringing new treatments to patients. This market encompasses a wide array of services designed to facilitate the planning, execution, management, and analysis of clinical trials, which are essential for evaluating the safety and efficacy of medical interventions before they are approved for widespread use. The Clinical Trials Support Services market is a dynamic and integral segment of the healthcare and pharmaceutical industries, playing a pivotal role in advancing medical research and bringing new treatments to patients. This market encompasses a wide array of services designed to facilitate the planning, execution, management, and analysis of clinical trials, which are essential for evaluating the safety and efficacy of medical interventions before they are approved for widespread use.

Clinical Trials Support Services market plays a pivotal role in advancing medical research and bringing new treatments to patients. As technological advancements and innovative approaches continue to shape the landscape, the market is poised for growth and evolution, driven by the shared goal of improving healthcare outcomes through rigorous and well-executed clinical trials.

Key Players in the Global Clinical Trials Support Services Market

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.

The major companies in clinical trials support services market are as follows:

  • Charles River Laboratories International, Inc.
  • Wuxi Apptec, Inc.
  • Iqvia Holdings, Inc.
  • Syneos Health, Inc.
  • Eurofins Scientific
  • Ppd, Inc. (Pharmaceutical Product Development)
  • Icon Plc
  • Laboratory Corporation of America Holdings (Labcorp)
  • Alcura
  • Parexel International Corporation
The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Clinical Trials Support Services Market Overview
3.1 Global Clinical Trials Support Services Market Historical Value (2017-2023)
3.2 Global Clinical Trials Support Services Market Forecast Value (2024-2032)
4 Global Clinical Trials Support Services Market Landscape
4.1 Global Clinical Trials Support Services Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Clinical Trials Support Services Product Landscape
4.2.1 Analysis by Service Type
4.2.2 Analysis by Phase
4.2.3 Analysis by Sponsor
5 Global Clinical Trials Support Services Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Clinical Trials Support Services Market Segmentation
6.1 Global Clinical Trials Support Services Market by Service Type
6.1.1 Market Overview
6.1.2 Clinical Trial Site Management
6.1.2.1 Patient Recruitment Management
6.1.2.2 Patient Recruitment and Registry Services
6.1.2.3 Patient Retention
6.1.2.4 Others
6.1.3 IRB
6.1.4 Data Management
6.1.5 Administrative staff
6.1.6 Others
6.2 Global Clinical Trials Support Services Market by Phase
6.2.1 Market Overview
6.2.2 Phase I
6.2.3 Phase II
6.2.4 Phase III
6.2.5 Phase IV
6.3 Global Clinical Trials Support Services Market by Manufacturing Sponsor
6.3.1 Market Overview
6.3.2 Pharmaceutical and Biopharmaceutical
6.3.3 Medical Devices
6.3.4 Others
6.4 Global Clinical Trials Support Services Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Clinical Trials Support Services Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Clinical Trials Support Services Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Clinical Trials Support Services Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Clinical Trials Support Services Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Clinical Trials Support Services Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Grants Analysis
12.1 Analysis by year
12.2 Analysis by Amount Awarded
12.3 Analysis by Issuing Authority
12.4 Analysis by Grant Application
12.5 Analysis by Funding Institute
12.6 Analysis by NIH Departments
12.7 Analysis by Recipient Organization
13 Funding Analysis
13.1 Analysis by Funding Instances
13.2 Analysis by Type of Funding
13.3 Analysis by Funding Amount
13.4 Analysis by Leading Players
13.5 Analysis by Leading Investors
13.6 Analysis by Geography
14 Partnership and Collaborations Analysis
14.1 Analysis by Partnership Instances
14.2 Analysis by Type of Partnership
14.3 Analysis by Leading Players
14.4 Analysis by Geography
15 Regulatory Framework
15.1 Regulatory Overview
15.1.1 US FDA
15.1.2 EU EMA
15.1.3 INDIA CDSCO
15.1.4 JAPAN PMDA
15.1.5 Others
16 Supplier Landscape
16.1 Charles River Laboratories International, Inc.
16.1.1 Financial Analysis
16.1.2 Product Portfolio
16.1.3 Demographic Reach and Achievements
16.1.4 Mergers and Acquisition
16.1.5 Certifications
16.2 Wuxi Apptec, Inc.
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisition
16.2.5 Certifications
16.3 Iqvia Holdings, Inc.
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisition
16.3.5 Certifications
16.4 Syneos Health, Inc.
16.4.1 Financial Analysis
16.4.2 Product Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Mergers and Acquisition
16.4.5 Certifications
16.5 Eurofins Scientific
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisition
16.5.5 Certifications
16.6 Ppd, Inc. (Pharmaceutical Product Development)
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisition
16.6.5 Certifications
16.7 Icon Plc
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisition
16.7.5 Certifications
16.8 Laboratory Corporation Of America Holdings (Labcorp)
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisition
16.8.5 Certifications
16.9 Alcura
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisition
16.9.5 Certifications
16.10 Parexel International Corporation
16.10.1 Financial Analysis
16.10.2 Product Portfolio
16.10.3 Demographic Reach and Achievements
16.10.4 Mergers and Acquisition
16.10.5 Certifications
17 Global Clinical Trials Support Services Market - Distribution Model (Additional Insight)
17.1 Overview
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket

Companies Mentioned

  • Charles River Laboratories International Inc.
  • Wuxi Apptec Inc.
  • Iqvia Holdings Inc.
  • Syneos Health Inc.
  • Eurofins Scientific Ppd Inc.
  • (Pharmaceutical Product Development) Icon Plc
  • Laboratory Corporation of America Holdings (Labcorp)
  • Alcura Parexel International Corporation

Methodology

Loading
LOADING...